Amsterdam Molecular Therapeutics Reports Half Year Re...((1414) (44) Result on deconso...)

Result on deconsolidation - 1,113

Result before corporate income taxes (8,640) (3,153)

Corporate income taxes - -

Result for the period (8,640) (3,153)

Attributable to:

Equity holders of the Company (8,640) (3,153)

Earnings per share for result

attributable to the equity holders of the

Company during the period

(expressed in Euro per share)

Basic and diluted earnings per share (0.97) (1.61)

AMSTERDAM MOLECULAR THERAPEUTICS HOLDING N.V.

Consolidated balance sheet

(after appropriation of result)

(In Euro x 1,000)

30 June 31 December

2007 2006

ASSETS

Non current assets

Intangible assets 1,540 1,540

Property, plant and equipment 1,463 1,091

3,003 2,631

Current assets

Receivables from related parties 862 1,202

Social security and other taxes 178 276

Other receivables 290 51

Cash and cash equivalents 56,283 14,058

57,613 15,587

Total assets 60,616 18,218

EQUITY

Shareholders' equity 52,260 (1,682)

Total group equity 52,260 (1,682)

LIABILITIES

Non-current liabilities

Loan from related party - 1,038

Liabil
'/>"/>